313 related articles for article (PubMed ID: 11683945)
1. Differential immunoreactivity of melanocytic lesions of the conjunctiva.
Sharara NA; Alexander RA; Luthert PJ; Hungerford JL; Cree IA
Histopathology; 2001 Oct; 39(4):426-31. PubMed ID: 11683945
[TBL] [Abstract][Full Text] [Related]
2. WT1 and Bcl2 expression in melanocytic lesions of the conjunctiva: an immunohistochemical study of 123 cases.
Furusato E; Hidayat AA; Man YG; Auerbach A; Furusato B; Rushing EJ
Arch Ophthalmol; 2009 Aug; 127(8):964-9. PubMed ID: 19667332
[TBL] [Abstract][Full Text] [Related]
3. Chemokine Receptor Expression Pattern Correlates to Progression of Conjunctival Melanocytic Lesions.
van Ipenburg JA; de Waard NE; Naus NC; Jager MJ; Paridaens D; Verdijk RM
Invest Ophthalmol Vis Sci; 2019 Jul; 60(8):2950-2957. PubMed ID: 31305861
[TBL] [Abstract][Full Text] [Related]
4. HMB-45 immunohistochemical staining of conjunctival melanocytic lesions.
McDonnell JM; Sun YY; Wagner D
Ophthalmology; 1991 Apr; 98(4):453-8. PubMed ID: 1711186
[TBL] [Abstract][Full Text] [Related]
5. Prevalence and implications of TERT promoter mutation in uveal and conjunctival melanoma and in benign and premalignant conjunctival melanocytic lesions.
Koopmans AE; Ober K; Dubbink HJ; Paridaens D; Naus NC; Belunek S; Krist B; Post E; Zwarthoff EC; de Klein A; Verdijk RM;
Invest Ophthalmol Vis Sci; 2014 Aug; 55(9):6024-30. PubMed ID: 25159205
[TBL] [Abstract][Full Text] [Related]
6. PRAME Expression in Junctional Melanocytic Proliferations of the Conjunctiva: A Potential Biomarker for Primary Acquired Melanosis/Conjunctival Melanocytic Intraepithelial Lesions.
Huang YY; Hrycaj SM; Chan MP; Stagner AM; Patel RM; Bresler SC
Am J Dermatopathol; 2022 Oct; 44(10):734-740. PubMed ID: 35475786
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical profiling including beta-catenin in conjunctival melanocytic lesions.
Reddy HS; Keene CD; Chang SH; Jian-Amadi A; Cimino PJ
Exp Mol Pathol; 2017 Apr; 102(2):198-202. PubMed ID: 28161440
[TBL] [Abstract][Full Text] [Related]
8. p16ink4a expression in benign and malignant melanocytic conjunctival lesions.
Zoroquiain P; Fernandes BF; González S; Novais GN; Schalper KA; Burnier MN
Int J Surg Pathol; 2012 Jun; 20(3):240-5. PubMed ID: 22287653
[TBL] [Abstract][Full Text] [Related]
9. Immunophenotypic markers to differentiate between benign and malignant melanocytic lesions.
Keijser S; Missotten GS; Bonfrer JM; de Wolff-Rouendaal D; Jager MJ; de Keizer RJ
Br J Ophthalmol; 2006 Feb; 90(2):213-7. PubMed ID: 16424536
[TBL] [Abstract][Full Text] [Related]
10. In vivo confocal microscopy of pigmented conjunctival tumors.
Messmer EM; Mackert MJ; Zapp DM; Kampik A
Graefes Arch Clin Exp Ophthalmol; 2006 Nov; 244(11):1437-45. PubMed ID: 16598465
[TBL] [Abstract][Full Text] [Related]
11. Finding of conjunctival melanocytic pigmented lesions within pterygium.
Perra MT; Colombari R; Maxia C; Zucca I; Piras F; Corbu A; Bravo S; Scarpa A; Sirigu P
Histopathology; 2006 Mar; 48(4):387-93. PubMed ID: 16487360
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical analysis of benign and malignant melanocytic lesions of the conjunctiva using double-staining.
Soon AK; Brownstein S; Tang T; Saleh S; Jiang K; Levac J; Blanco P; Farmer J
Can J Ophthalmol; 2019 Dec; 54(6):699-707. PubMed ID: 31836103
[TBL] [Abstract][Full Text] [Related]
13. Incidence of melanocytic lesions of the conjunctiva in a review of 10 675 ophthalmic specimens.
Novais GA; Fernandes BF; Belfort RN; Castiglione E; Cheema DP; Burnier MN
Int J Surg Pathol; 2010 Feb; 18(1):60-3. PubMed ID: 18611943
[TBL] [Abstract][Full Text] [Related]
14. Primary acquired melanosis of the conjunctiva: risks for progression to melanoma in 311 eyes. The 2006 Lorenz E. Zimmerman lecture.
Shields JA; Shields CL; Mashayekhi A; Marr BP; Benavides R; Thangappan A; Phan L; Eagle RC
Ophthalmology; 2008 Mar; 115(3):511-519.e2. PubMed ID: 17884168
[TBL] [Abstract][Full Text] [Related]
15. Conjunctival melanosis and melanoma.
Folberg R; McLean IW; Zimmerman LE
Ophthalmology; 1984 Jun; 91(6):673-8. PubMed ID: 6462625
[TBL] [Abstract][Full Text] [Related]
16. [Immunohistochemical markers for cytoplasmic antigens in acquired melanosis, malignant melanomas, and nevi of the conjunctiva].
Hitzer S; Bialasiewicz AA; Richard G
Klin Monbl Augenheilkd; 1998 Oct; 213(4):230-7. PubMed ID: 9848068
[TBL] [Abstract][Full Text] [Related]
17. Pigmented conjunctival neoplasms.
Rodriguez-Sains RS
Orbit; 2002 Sep; 21(3):231-8. PubMed ID: 12187419
[TBL] [Abstract][Full Text] [Related]
18. Expression of sex hormone receptors and cell cycle proteins in melanocytic lesions of the ocular conjunctiva.
Pache M; Glatz-Krieger K; Sauter G; Meyer P
Graefes Arch Clin Exp Ophthalmol; 2006 Jan; 244(1):113-7. PubMed ID: 16003514
[TBL] [Abstract][Full Text] [Related]
19. PRAME immunohistochemistry is useful in the evaluation of conjunctival melanomas, nevi, and primary acquired melanosis.
LeBlanc RE; Miller DM; Zegans ME
J Cutan Pathol; 2021 Dec; 48(12):1442-1448. PubMed ID: 34089198
[TBL] [Abstract][Full Text] [Related]
20. Usefulness of a red chromagen in the diagnosis of melanocytic lesions of the conjunctiva.
Jiang K; Brownstein S; Lam K; Burns B; Farmer J
JAMA Ophthalmol; 2014 May; 132(5):622-9. PubMed ID: 24626521
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
